- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A nurse complained a Ferinject brochure implied CosmoFer required a 6-hour infusion, causing anxiety about correct administration. Panel relied on an earlier…
GSK’s ESC 2009 symposium invite was held not to be disguised promotion, but because it referenced ambrisentan it was promotional and needed…
Consultants alleged Lilly’s Strattera Support Service meant company staff contacted patients and could give biased advice. Panel found contact was via independent…
Lilly was found in breach after a branded promotional presentation appeared to be part of a university diabetes course, and for an…
P&G’s Asacol materials used “confidence in colitis” without clear qualification, implying use across all colitis types (breach 3.2). A leavepiece also used…
BMJ criticised a five-star GP recruitment meeting for a Pfizer-funded celecoxib safety study and lack of funding disclosure. Panel found breaches, but…
A pharmacist alleged a Pfizer commercial account manager discussed pricing for generic losartan before it was licensed. Panel noted a price list…
Complaint alleged a Daiichi-Sankyo rep said a medicines management team would be disbanded, potentially misleading GPs to prescribe Olmetec. Panel couldn’t prove…
Financial Times alleged Roche pressured staff to sell Tamiflu to non-doctors and used cash payments/discounts. Panel found unclear internal guidance/certification issues but…
PMCPA found Bracco in breach after a representative had not completed the ABPI exam within the required timeframe and a CT injector…
A Merz representative set up an Instagram account for business and posted images including a Bocouture pack shot. The Panel ruled this…
Employee alleged reps influenced advisory board invitees, meeting was disguised promotion, and neutropenia discussions compromised safety and PV. Panel had concerns but…
Complaint alleged off-label weight loss/CV superiority promotion for Ozempic. Panel/Appeal Board found no off-label breach, but ruled materials unclear on SUSTAIN 6…
Cephalon’s internal congress feedback note described “clubbing” and late-night bars with HCPs and urged “lets make sure they start Rxing now!”. PMCPA…
Anonymous GP alleged a sponsored contraception update was disguised promotion and that a Bayer representative bullied delegates. Panel found sponsorship was clear…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.